<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00273481</url>
  </required_header>
  <id_info>
    <org_study_id>PRN 05-001</org_study_id>
    <nct_id>NCT00273481</nct_id>
  </id_info>
  <brief_title>Cosopt Versus Xalacom</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pharmaceutical Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pharmaceutical Research Network</source>
  <brief_summary>
    <textblock>
      To compare the intraocular pressure efficacy and safety of the DTFC given twice daily versus
      the LTFC given once every morning following a run-in period with timolol maleate given twice
      daily.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">April 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>33</enrollment>
  <condition>Open-Angle Glaucoma</condition>
  <condition>Ocular Hypertension</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dorzolamide 2%/timolol maleate 0.5% fixed combination</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>latanoprost 0.005%/timolol maleate 0.5% fixed combination</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>timolol maleate 0.5%</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults with primary open-angle or pigment-dispersion glaucoma, or ocular hypertension

          -  at baseline the intraocular pressure should be 20 to 32 mm Hg inclusive at 08:00
             measurement (Visit 2) after dosing with timolol the evening before

          -  the intraocular pressure should be 32 mm Hg or less at all the time points in both
             eyes at Visit 2

          -  visual acuity should be 6/60 or better in the study eye(s)

        Exclusion Criteria:

          -  any anticipated change in systemic hypotensive therapy during the trial

          -  use of any corticosteroids by any route for more than two weeks during the study

          -  contraindications to study medicines
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William C. Stewart, MD</last_name>
    <role>Study Director</role>
    <affiliation>Pharmaceutical Research Network, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cindy M. Hutnik, BSc, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lawson Health Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Barbara Cvenkel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Eye Clinic Ljubljana</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lawson Health Research Insitute</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Eye Clinic</name>
      <address>
        <city>Ljubljana</city>
        <zip>A525</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2006</study_first_submitted>
  <study_first_submitted_qc>January 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2006</study_first_posted>
  <last_update_submitted>November 18, 2008</last_update_submitted>
  <last_update_submitted_qc>November 18, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Ocular Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Timolol</mesh_term>
    <mesh_term>Latanoprost</mesh_term>
    <mesh_term>Dorzolamide</mesh_term>
    <mesh_term>Maleic acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

